ANGO
AngioDynamics·NASDAQ
--
--(--)
--
--(--)
ANGO fundamentals
AngioDynamics (ANGO) Revenue Breakdown: Q2 2026 Business & Regional Performance
AngioDynamics (ANGO) reported total revenue of 79.43M USD in Q2 2026, with its core business segment Med Tech contributing 44.88%. Regionally, United States remained the largest market, accounting for 85.10% of total revenue. Explore AngioDynamics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
AngioDynamics (ANGO) reported total revenue of 79.43M USD in Q2 2026, with its core business segment Med Tech contributing 44.88%. Regionally, United States remained the largest market, accounting for 85.10% of total revenue. Explore AngioDynamics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for AngioDynamics year over year?What were the key takeaways from AngioDynamics's earnings call?What guidance did AngioDynamics's management provide for the next earnings period?What is the market's earnings forecast for AngioDynamics next quarter?What were the key takeaways from AngioDynamics’s earnings call?Did AngioDynamics beat or miss consensus estimates last quarter?What is AngioDynamics's gross profit margin?What does AngioDynamics do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
